One Scientist’s Plan to Regenerate Beta Cells in Boston
Can we internally regenerate and protect beta cells, and therefore find cures for type 1 diabetes (T1D)? One scientist thinks…
ViaCyte Does it Again: Insulin Production in People with T1D
ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, has shown—for the first time ever—that its PEC-Direct therapy…
Breakthrough T1D Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research
Breakthrough T1D today launched its first Center of Excellence, a new research and funding model aimed at accelerating leading type…
Semma Therapeutics, Backed by the T1D Fund, Acquired by Major Biopharma Company
In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September…
Breakthrough T1D Hosts 3D Bioprinting Workshop for Type 1 Diabetes
Breakthrough T1D is committed to developing cell replacement therapies that will one day offer cures for type 1 diabetes (T1D).…
Enhanced Local Immune Suppression: Hope for Beta Cell Replacement Therapies
Medical devices such as pacemakers and stents that can be implanted in a human body have helped many people lead…
Sanjoy Dutta, Ph.D.: The Beginning of the ADA Scientific Sessions
The ADA’s Scientific Sessions has begun! Here, in the first recap, is Sanjoy Dutta, Ph.D., who highlights beta cell replacement…
Breakthrough T1D Beta Cell Replacement Consortium: Sharing Data and Resources, Saving Time and Money
The Breakthrough T1D Spring Beta Cell Replacement Consortium meeting, held recently in NYC, allowed 55 researchers from a diversity of…
Want to Stave Off Type 1 Diabetes? Beta Cell Proliferation May Be the Key
In Nature Metabolism, Breakthrough T1D-funded researchers—including the lead author, Ercument Dirice, Ph.D., and senior author, Rohit Kulkarni, M.D., Ph.D.—found an…
The 20th Anniversary of the Edmonton Protocol
This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999,…
